Reuters logo
BRIEF-Bayer, J&J to study Xarelto for pulmonary embolism, DVT in cancer patients
May 28, 2015 / 12:36 PM / 3 years ago

BRIEF-Bayer, J&J to study Xarelto for pulmonary embolism, DVT in cancer patients

May 28 (Reuters) - Bayer

* And partner J&J say to initiate study to explore xarelto in prevention and treatment of pulmonary embolism and deep vein thrombosis in cancer patients Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below